Period Ending | Mar 31, 2009 | Mar 31, 2008 | Mar 31, 2007 |
Total Revenue
|
79,618,928
|
89,601,281
|
70,513,408
| Cost of Revenue | 63,945,789 | 68,885,313 | 54,652,433 | |
Gross Profit
|
15,673,139
|
20,715,969
|
15,860,975
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
|
Selling General and Administrative | 17,366,109 | 17,315,895 | 15,201,630 |
|
Non Recurring | 394,572 | (382,194) | 49,470 |
|
Others |
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
| | |
Operating Income or Loss
|
(2,087,542)
|
3,782,268
|
609,875
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 795,201 | 1,159,137 | 489,303 |
|
Earnings Before Interest And Taxes | (1,550,964) | 4,941,405 | 1,099,178 |
|
Interest Expense | 251,073 | 231,603 | 231,863 |
|
Income Before Tax | (1,802,037) | 4,709,802 | 867,315 |
|
Income Tax Expense | (749,232) | 2,055,128 | 458,048 |
|
Minority Interest | 33,743 | 58,368 | (4,038) |
|
|
|
Net Income From Continuing Ops | (1,019,061) | 3,731,294 | 1,073,788 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
| | |
Net Income
|
(1,019,061)
|
3,731,294
|
1,073,788
| Preferred Stock And Other Adjustments |
-
|
-
|
-
| |
Net Income Applicable To Common Shares
|
($1,019,061)
|
$3,731,294
|
$1,073,788
|
|